← Human Trials & Peer-Reviewed Studies
Vitamin D status and clinical implications in the adult population of Malaysia: a position paper by the Malaysian Vitamin D Special Interest Group.
Plain-language guide to PMID 37430004 (2023): review of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 37430004
- Journal
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
- Year
- 2023
- Study type
- Review
- Authors
- Lee JK et al. (14 authors)
- DOI
- 10.1007/s00198-023-06841-4
What This Paper Covers, in Plain Language
What It Covers
Researchers studied Vitamin D, K2, Magnesium and Zinc in this review publication.
Vitamin D deficiency and insufficiency is common among populations globally, and in Asia and Malaysia.
The purpose of this Position Paper is to propose recommendations for both clinicians and non-clinicians to promote vitamin D sufficiency in Malaysian adults.
Who the Included Studies Covered
By PubMed's age tags, the people studied were adults.
Literature reviews were undertaken to inform summaries of the following: vitamin D status globally and in Asian and Malaysian populations, vitamin D status among individuals with common medical conditions, and current recommendations to achieve vitamin D sufficiency through sun exposure, food intake and supplementation.
Recommendations were based on the findings of the literature reviews, recent European guidance on vitamin D supplementation, the 2018 road map for action on vitamin D in low- and middle-income countries, and research recommendations proposed by the Malaysian Ministry of Health in 2017.
What Was Measured
The subject headings attached to it are Vitamin D Deficiency, Malaysia, Vitamin D, Dietary Supplements, Sunlight, Food, Fortified and Nutritional Status.
The authors tagged it with the keywords Sun exposure and Supplementation.
What This Means in Plain Language
This is a review of Vitamin D, K2, Magnesium and Zinc.
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2023 (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.